I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The list of search strategies and final results on each dat..:
Nima Hajizadeh
;
Amirhossein Heidari
;
Sara Sadeghi
.
doi:10.1371/journal.pone.0293433.s003. , 2024
Link:
https://doi.org/10.1371/journal.pone.0293433.s003
RT Journal T1
The list of search strategies and final results on each database and register
UL https://suche.suub.uni-bremen.de/peid=base-ftgriffithunifig:oai:figshare.com:article_25198518&Exemplar=1&LAN=DE A1 Nima Hajizadeh A1 Amirhossein Heidari A1 Sara Sadeghi A1 Azadeh Goodarzi YR 2024 K1 Biochemistry K1 Medicine K1 Pharmacology K1 Biotechnology K1 Immunology K1 Cancer K1 Infectious Diseases K1 Virology K1 Chemical Sciences not elsewhere classified K1 tumor necrosis factor K1 thorough systematic search K1 permanent hair loss K1 mostly favorable results K1 minimal adverse effects K1 532 relevant records K1 56 studies met K1 many ca subtypes K1 induce temporary improvement K1 especially oral tofacitinib K1 certolizumab pegol caused K1 another tnf inhibitor K1 anonymous tnf inhibitor K1 induced paradoxical ca K1 another jak inhibitor K1 janus kinase inhibitors K1 causing mild aes K1 oral tofacitinib K1 janus kinase K1 tnf inhibitor K1 extensive studies K1 sustained improvement K1 stable improvement K1 significant improvement K1 primary ca K1 tnf inhibitors K1 adalimumab induced K1 xlink "> K1 various conditions K1 tolerable aes K1 severe aes K1 regular basis K1 regarding immune K1 recommended jak K1 probable aes K1 previous medications K1 particularly neuropathies K1 new modality K1 monitoring aes K1 mediated pathophysiology K1 incomplete amelioration JF doi:10.1371/journal.pone.0293433.s003 LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0293433.s003 DO https://doi.org/10.1371/journal.pone.0293433.s003 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)